GOLDMAN SACHS GROUP INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,912,000
-0.1%
5,000,0000.0%0.00%0.0%
Q2 2021$4,916,000
-47.4%
5,000,000
-48.4%
0.00%
-50.0%
Q1 2021$9,344,000
+47.2%
9,693,000
+44.8%
0.00%0.0%
Q4 2020$6,347,000
-37.4%
6,693,000
-39.2%
0.00%
-33.3%
Q3 2020$10,132,000
-23.2%
11,000,000
-26.7%
0.00%
-25.0%
Q2 2020$13,201,000
-12.3%
15,000,000
-20.0%
0.00%
-20.0%
Q1 2020$15,057,000
+115.3%
18,752,000
+142.7%
0.01%
+150.0%
Q4 2019$6,992,0007,725,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 90,815,000$90,802,6815.68%
PIPER SANDLER & CO. 6,695,000$6,694,0634.58%
Opti Capital Management, LP 46,902,000$46,902,0003.79%
Monashee Investment Management LLC 9,000,000$8,975,1602.48%
TENOR CAPITAL MANAGEMENT Co., L.P. 96,994,000$97,297,0841.93%
DeepCurrents Investment Group LLC 41,092,000$40,966,1771.60%
Sonora Investment Management Group, LLC 9,395,000$9,387,5820.82%
Penn Mutual Asset Management 675,000$677,0180.64%
OAKTREE CAPITAL MANAGEMENT LP 19,540,000$19,586,1990.22%
BRAIDWELL LP 6,500,000$6,515,3680.22%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders